Acute Lymphoblastic Leukemia

 

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Original Editors -  Erin Foster from Bellarmine University's Pathophysiology of Complex Patient Problems project.

Lead Editors - Your name will be added here if you are a lead editor on this page.  Read more.

Definition/Description
[edit | edit source]

Acute lymphoblastic leukemia (ALL) is a cancer of the blood and bone marrow. Bone marrow is spongy tissue that fills the cavity of the long bones consisting of fat, red blood cells, and white blood cells. ALL affects the immature white blood cells. This type of cancer is classified by one of two subtypes.

The two subtypes include:

B-cell

  • Common ALL (50% of cases)
  • Early Pre-B ALL (10% of cases)
  • Pre-B ALL (10% of cases)
  • Mature B-cell ALL (4% of cases)

T-cell

  • Pre-T ALL (5-10% of cases)
  • Mature T-cell (15-20% of cases)


Prognostic factors include:

  • Age
  • White blood cell count
  • ALL subtype
  • Certain test results
  • Response to treatment

Prevalence
[edit | edit source]

ALL is the most common cancer occurring in children today and can occur in some adult cases. Children are at the highest risk between 2 and 4 years of age. This risk decreases from age 4 to mid-20s, increasing again after age 50. The average person has a 1 in 1,000 chance of getting ALL. The American Cancer Society estimated the following statistics for 2010:

  • Approximately 43,050 new cases of all types of leukemia.
  • Approximately 5,330 new cases of acute lymphoblastic leukemia (1 out of 3 were adult cases).
  • Approximately 1,420 deaths from ALL (3 out of 4 were adult cases).

Characteristics/Clinical Presentation[edit | edit source]

Most signs and symptoms of ALL mimic those of the flu. However, with ALL these signs and symptoms will not improve. Signs and symptoms include:

  • Bleeding from the gums
  • Nosebleeds
  • Pale skin
  • Shortness of breath
  • Fever
  • Frequent infections
  • Weakness
  • Fatigue
  • Swollen lymph nodes (neck, underarm, groin, stomach)

Associated Co-morbidities[edit | edit source]

The following co-morbidities are linked to ALL:

  • Anemia
  • Diabetes
  • Lupus
  • Rheumatoid Arthritis
  • Multiple Sclerosis

Medications[edit | edit source]

Medications involved with ALL include:

  • Gleevec
  • Adriamycin
  • Purinethol
  • Sprycel
  • Trexall
  • Oncaspar
  • Arranon
  • Clolar
  • Vumon

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

add text here

Etiology/Causes[edit | edit source]

add text here

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)[edit | edit source]

add text here

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Alternative/Holistic Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

add appropriate resources here

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10

References[edit | edit source]

see adding references tutorial.